JMIR Publications

ABSTRACT

Background:

There is growing evidence that apps and digital interventions have a positive impact on diabetes self-management. Standard self-management for patients with diabetes could therefore be supplemented by apps and digital interventions to increase patients’ skills. Several initiatives, models and frameworks suggest how health apps and digital interventions could be evaluated, but there are few standards for this. And although there are many methods for evaluating apps and digital interventions, a more specific approach might be needed for assessing digital diabetes self-management interventions.

Objective:

This review aims to identify which methods and criteria are used to evaluate apps and digital interventions for diabetes self-management, and to describe how patients were involved in these evaluations.

Methods:

We searched CINAHL, EMBASE, MEDLINE, and Web of Science for articles published from 2015 that referred to the evaluation of apps and digital interventions for diabetes self-management and involved patients in the evaluation. We then conducted a narrative qualitative synthesis of the findings, structured around the included studies’ quality, methods of evaluation and evaluation criteria.

Results:

Of 1681 articles identified, 31 fulfilled the inclusion criteria. Seven (7) articles were considered of high confidence in the evidence. Apps were the most commonly used platform for diabetes self-management (18/31), and T2D was the targeted health condition most studies focused on (12/31). Questionnaires, interviews, and user-group meetings were the most common methods of evaluation. Furthermore, the most evaluated criteria for apps and digital diabetes self-management interventions were cognitive impact, clinical impact, and usability. Feasibility and security and privacy were not evaluated by studies considered of high confidence in the evidence.

Conclusions:

There were few studies with high confidence in the evidence that involved patients in the evaluation of apps and digital interventions for diabetes self-management. Additional evaluation criteria, such as the sustainability, gender and equity issues, should be focused on more in future studies, to provide a better understanding of the effects and potential of apps and digital interventions for diabetes self-management. Clinical Trial: PROSPERO (Registration number: CRD42018115246)